ATE424817T1 - Topische analgetische zusammensetzungen enthaltend aliphatische polyamine und methoden für ihre verwendung - Google Patents
Topische analgetische zusammensetzungen enthaltend aliphatische polyamine und methoden für ihre verwendungInfo
- Publication number
- ATE424817T1 ATE424817T1 AT01973897T AT01973897T ATE424817T1 AT E424817 T1 ATE424817 T1 AT E424817T1 AT 01973897 T AT01973897 T AT 01973897T AT 01973897 T AT01973897 T AT 01973897T AT E424817 T1 ATE424817 T1 AT E424817T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- compositions containing
- containing aliphatic
- aliphatic polyamines
- topical analgesic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 229920000768 polyamine Polymers 0.000 title abstract 3
- 230000000202 analgesic effect Effects 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 abstract 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 abstract 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 abstract 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 abstract 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- 239000005700 Putrescine Substances 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 150000003973 alkyl amines Chemical class 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000036592 analgesia Effects 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 229960004194 lidocaine Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229940063673 spermidine Drugs 0.000 abstract 1
- 229940063675 spermine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23348800P | 2000-09-19 | 2000-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE424817T1 true ATE424817T1 (de) | 2009-03-15 |
Family
ID=22877452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01973897T ATE424817T1 (de) | 2000-09-19 | 2001-09-19 | Topische analgetische zusammensetzungen enthaltend aliphatische polyamine und methoden für ihre verwendung |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20040039057A1 (de) |
| EP (1) | EP1318801B1 (de) |
| AT (1) | ATE424817T1 (de) |
| AU (1) | AU2001293559A1 (de) |
| CA (1) | CA2422531C (de) |
| DE (1) | DE60137946D1 (de) |
| WO (1) | WO2002024185A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL146126A0 (en) * | 1999-04-30 | 2002-07-25 | Slil Biomedical Corp | Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases |
| DE60029944T2 (de) * | 1999-04-30 | 2007-04-05 | Cellgate, Inc., Redwood City | Polyamine und ihre therapeutische verwendung |
| US7312244B2 (en) * | 1999-04-30 | 2007-12-25 | Cellgate, Inc. | Polyamine analog-amino acid conjugates useful as anticancer agents |
| US20030130356A1 (en) * | 2001-10-16 | 2003-07-10 | Slil Biomedical Corporation | Oligoamine compounds and derivatives thereof for cancer therapy |
| WO2008091161A1 (en) * | 2007-01-26 | 2008-07-31 | Fridtjof Bjerke | Cosmetic composition containing spermine and emu oil |
| DE102008064214A1 (de) | 2008-12-22 | 2010-06-24 | Klosterfrau Berlin Gmbh | Lokalanästhetikum zur Linderung von Brustschmerz |
| WO2012176668A1 (ja) * | 2011-06-20 | 2012-12-27 | 久光製薬株式会社 | リドカイン含有パップ剤 |
| RU2648441C2 (ru) * | 2016-09-13 | 2018-03-26 | Казимир Иосифович Пашкевич | Средство для местной анестезии (варианты) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4752620A (en) * | 1986-11-21 | 1988-06-21 | David Roberts | Method of treating pain with urea and glyoxal compositions |
| IL95642A0 (en) * | 1989-09-15 | 1991-06-30 | Pehrom Pharmaceutical Corp | Topical preparations for treatment of ulcers and other lesions |
| JP2849937B2 (ja) * | 1990-04-18 | 1999-01-27 | 日東電工株式会社 | 医療用貼付剤 |
| US5654337A (en) * | 1995-03-24 | 1997-08-05 | II William Scott Snyder | Topical formulation for local delivery of a pharmaceutically active agent |
| US5980918A (en) * | 1997-10-24 | 1999-11-09 | Brennen Medical, Inc. | β-D-glucan topical composition |
| FR2775901B1 (fr) * | 1998-03-13 | 2000-07-21 | Logeais Labor Jacques | Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments |
-
2001
- 2001-09-19 AT AT01973897T patent/ATE424817T1/de not_active IP Right Cessation
- 2001-09-19 US US10/380,675 patent/US20040039057A1/en not_active Abandoned
- 2001-09-19 DE DE60137946T patent/DE60137946D1/de not_active Expired - Lifetime
- 2001-09-19 WO PCT/CA2001/001337 patent/WO2002024185A2/en not_active Ceased
- 2001-09-19 CA CA2422531A patent/CA2422531C/en not_active Expired - Fee Related
- 2001-09-19 EP EP01973897A patent/EP1318801B1/de not_active Expired - Lifetime
- 2001-09-19 AU AU2001293559A patent/AU2001293559A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1318801A2 (de) | 2003-06-18 |
| WO2002024185A2 (en) | 2002-03-28 |
| EP1318801B1 (de) | 2009-03-11 |
| CA2422531A1 (en) | 2002-03-28 |
| DE60137946D1 (de) | 2009-04-23 |
| WO2002024185A3 (en) | 2002-09-06 |
| US20040039057A1 (en) | 2004-02-26 |
| AU2001293559A1 (en) | 2002-04-02 |
| CA2422531C (en) | 2011-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE424817T1 (de) | Topische analgetische zusammensetzungen enthaltend aliphatische polyamine und methoden für ihre verwendung | |
| TR200201004T2 (tr) | Monoamin reuptake önleyicileri olarak biaril eter türevleri | |
| TR200200376T2 (tr) | Aşırı şişmanlık tedavisi için planlanan ilaçların üretiminde monoamin oksidaz inhibitörlerinin kullanımı | |
| DE602004010413D1 (de) | Vorrichtung und Verfahren für zwei oder mehrere "delivery traffic indication message (DTIM)" Perioden in drahtlosen Netzen | |
| UA88464C2 (ru) | Способ дермального введения метадоновой композиции с обеспечением системного действия | |
| ATE250977T1 (de) | Nickel-enthaltender hydrierkatalysator und verfahren zu seiner herstellung | |
| AR046933A1 (es) | Eficacia de humectacion mejorada mediante el uso de hidroxialquilurea | |
| BR0008958A (pt) | Inibidores de reabsorção de monoamina para otratamento de distúrbios do snc | |
| NO20065483L (no) | Kombinasjoner omfattende antimuskarinmidler og PDE4-inhibitorer | |
| CA2591867A1 (en) | Cooling topical patch preparation | |
| CO5670369A2 (es) | Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos | |
| BRPI0417586A (pt) | método para se reportar o estado de um usuário de um dispositivo de comunicação móvel e dispositivo de comunicação móvel para uso em um sistema de comunicação móvel | |
| MY131964A (en) | 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors | |
| ATE395050T1 (de) | Transdermales therapeutisches system für die verabreichung carboxylgruppenhaltiger, nichtsteroidaler antiphlogistika, sowie verfahren zu seiner herstellung | |
| SG152257A1 (en) | Topical preparation containing ambroxol | |
| TW200602076A (en) | O, O'-amidomalonate and N, O-amidomalonate platinum complexes | |
| UA87513C2 (ru) | Фармацевтическая композиция, содержащая дроспиренон и этинилэстрадиол | |
| Mutmainah et al. | Work motivation affects the performance of health workers | |
| ATE300593T1 (de) | Kühlmittel für brennstoffzellen | |
| MXPA05012297A (es) | Indazol que tiene actividad analgesica. | |
| ATE553627T1 (de) | Umlenkung des datenflusses eines sekundär-pdp zu einem primär-pdp vor der herstellung des sekundär-pdp-kontexts | |
| CO5290298A1 (es) | Acumulacion de poliamina en plantas | |
| Yuan | RESHUFFLING AN INDUSTRY | |
| CN210119928U (zh) | 用于角钢铁塔的标识牌安装金具 | |
| Tsuyoshi | Some collaborative work between Japan and China focusing on desertification of grassland during the last 10 years based on questionnaires |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |